179
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Analysis of policies for use of medically important antibiotics in animals in Namibia: implications for antimicrobial stewardship

, , ORCID Icon & ORCID Icon
Pages 1365-1379 | Received 24 Jul 2021, Accepted 19 Jul 2022, Published online: 11 Sep 2022

References

  • Fenollar F, Mediannikov O. Emerging infectious diseases in Africa in the 21st century. New Microbes New Infect. 2018;26:S10–S18.
  • Elton L, Haider N, Kock R, et al. Zoonotic disease preparedness in sub-Saharan African countries. One Health Outlook [Internet]. 2021;3(1):5. [cited 2022 May 6]. Available from: https://onehealthoutlook.biomedcentral.com/articles/10.1186/s42522-021-00037-8
  • Van TTH, Yidana Z, Smooker PM, et al. Antibiotic use in food animals worldwide, with a focus on Africa: pluses and minuses. J Glob Antimicrob Resist. 2020;20:170–177 .
  • Kimera ZI, Mshana SE, Rweyemamu MM, et al. Antimicrobial use and resistance in food-producing animals and the environment: an African perspective. Antimicrob Resist Infect Control [Internet]. 2020;9(1):37. [cited 2022 May 6]. Available from: https://aricjournal.biomedcentral.com/articles/10.1186/s13756-020-0697-x
  • Selaledi LA, Hassan ZM, Manyelo TG, et al. The current status of the alternative use to antibiotics in poultry production: an African perspective. Antibiotics [Internet]. 2020;9:1–18. [cited 2022 May 6]. Available from: https://www.mdpi.com/2079-6382/9/9/594
  • Godman B, Egwuenu A, Haque M, et al. Strategies to improve antimicrobial utilization with a special focus on developing countries. Life. 2021;11(6):528 .
  • Forman S, Hungerford N, Yamakawa M, et al. Climate change impacts and risks for animal health in Asia. OIE Rev Sci Tech. 2008:581-597.
  • Alonso CA, Zarazaga M, Ben Sallem R, et al. Antibiotic resistance in Escherichia coli in husbandry animals: the African perspective. Lett Appl Microbiol. 2017;64(5):318–334.
  • Kalungia AC, Burger J, Godman B, et al. Non-prescription sale and dispensing of antibiotics in community pharmacies in Zambia. Expert Rev Anti Infect Ther. 2016;14(12):1215–1223. [cited 2022 May 6]. Available from: https://www.tandfonline.com/doi/full/10.1080/14787210.2016.1227702
  • Belachew SA, Hall L, Selvey LA. Non-prescription dispensing of antibiotic agents among community drug retail outlets in sub-Saharan African countries: a systematic review and meta-analysis.Antimicrob Resist Infect Control. 2021;10(1):13.
  • Daghrir R, Drogui P. Tetracycline antibiotics in the environment: a review. Environ Chem Lett. 2013;11(3):209–227.
  • Hughes P, Heritage J. Antibiotic growth-promoters in food animals. In assessing quality and safety of animal feeds. Assessing Qual Saf Anim Feed. 2004;129–153. [cited 2022 May 5]. Available from:https://www.cabdirect.org/cabdirect/abstract/20053048769.
  • Forman S, Hungerford N, Yamakawa M, et al. Climate change impacts and risks for animal health in Asia. Rev Sci Tech. 2008;6(2):581–597. [cited 2022 May 5].
  • Van Boeckel TP, Glennon EE, Chen D, et al. Reducing antimicrobial use in food animals. Science [Internet]. 2017;357(6358):1350–1352. [cited 2022 May 5]. Available from: https://www.science.org/doi/10.1126/science.aao1495
  • Tiseo K, Huber L, Gilbert M, et al. Global trends in antimicrobial use in food animals from 2017 to 2030. Antibiotics [Internet]. 2020;9(12):918. [cited 2022 May 5]. Available from: https://www.mdpi.com/2079-6382/9/12/918
  • Aidara-Kane A, Angulo FJ, Conly J, et al. World health organization (WHO) guidelines on use of medically important antimicrobials in food-producing animals. Antimicrob Resist Infect Control. 2018;7(1):1–8 .
  • The Pew Charitable Trusts. FDA policies on antibiotic use in food animals. 2016.
  • WHO. Global antimicrobial resistance and use surveillance system (GLASS) report 2021 [Internet]. World Heal. Organ. 2021. [cited 2022 May 4]. Available from: http://www.who.int/glass/resources/publications/early-implementation-report-2020/en/
  • Sharland M, Pulcini C, Harbarth S, et al. Classifying antibiotics in the WHO essential medicines list for optimal use-be AWaRe. Lancet Infect Dis. 2018;18(1):18–20.
  • Sharland M, Gandra S, Huttner B, et al. Encouraging AWaRe-ness and discouraging inappropriate antibiotic use-the new 2019 essential medicines list becomes a global antibiotic stewardship tool. Lancet Infect Dis. 2019;19(12):1278–1280.
  • Saleem Z, Hassali MA, Godman B, et al. Sale of WHO AWaRe groups antibiotics without a prescription in Pakistan: a simulated client study. J Pharm Policy Pract. 2020;13(1):26.
  • Klein EY, Milkowska-Shibata M, Tseng KK, et al. Assessment of WHO antibiotic consumption and access targets in 76 countries, 2000–15: an analysis of pharmaceutical sales data. Lancet Infect Dis. 2021;21(1):107–115.
  • Kimera Z, Mshana SE, ML RMM, et al. Antimicrobial use and resistance in food producing animals and the environment: an African perspective. BMC. 2020;9:1–12.
  • Kümmerer K. Antibiotics in the aquatic environment - A review - Part I. Chemosphere [Internet]. 2009.
  • Haakuria VM, Pyatt AZ, Mansbridge S. Exploration of veterinary service supply to rural farmers in Namibia: a one health perspective. PAMJ - One Health [Internet]. 2020;2. [cited 2022 May 6]. Available from: https://www.one-health.panafrican-med-journal.com/content/article/2/17/full
  • Madzingira O, Simasiku S. A survey of the usage and storage practices of veterinary medicines among communal cattle farmers in the Kabbe South Constituency, Zambezi region. Wijas. 2020;2:61–69.
  • Racloz V, Presi P, Vounatsou P, et al. Use of mapping and statistical modelling for the prediction of bluetongue occurrence in Switzerland based on vector biology. Vet Ital. 2007;43(3):513–518.
  • Taylor M. Protozoal disease in cattle and sheep. Pract. 2000;22(10):604–617.
  • Casadevall A, Pirofski LA. Accidental virulence, cryptic pathogenesis, martians, lost hosts, and the pathogenicity of environmental microbes. Eukaryot Cell. 2007;6(12):2169–2174.
  • McEachran AD, Blackwell BR, Hanson JD, et al. Antibiotics, bacteria, and antibiotic resistance genes: aerial transport from cattle feed yards via particulate matter. Environ Health Perspect. 2015;123(4):337–343.
  • Holloway K, Van Dijk L. The world medicines situation: rational use of medicines. 3rd ed. World Med. Situat ed. GENEVA: World Health Organisation; 2011.
  • Delgado CL. Rising consumption of meat and milk in developing countries has created a new food revolution.J Nutr. 2003;133(11):3907S–3910S.
  • Godman B, Egwuenu A, Wesangula E et al. Tackling antimicrobial resistance across sub-Saharan Africa; current challenges and implications for the future. Expert Opinion on Drug Safety. 2022;21:1089–111.
  • Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399:629–655.
  • Mendelson M, Brink A, Gouws J, et al. The one health stewardship of colistin as an antibiotic of last resort for human health in South Africa. Lancet Infect Dis. 2018;18 (9):e288–e294.
  • Tadesse BT, Ashley EA, Ongarello S, et al. Antimicrobial resistance in Africa: a systematic review. BMC Infect Dis. 2017;17(1):616.
  • Essack SY, Desta AT, Abotsi RE AE. Antimicrobial resistance in the WHO African region: current status and roadmap for action. J public Heal (Oxford, England). 2017;39:8–13.
  • Ofori-Asenso R, Brhlikova P, Pollock AM. Prescribing indicators at primary health care centers within the WHO African region: a systematic analysis (1995-2015). BMC Public Health [Internet]. 2016;16 (1):724. [cited 2022 May 5]. Available from. http://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-016-3428-8
  • USAID, SIAPS. Containing Antimicrobial Resistance through Rational Antimicrobial Use in Namibia. 2018. Available at URL: https://siapsprogram.org/wp-content/uploads/2018/06/18-068-Technical-report-on-combating-AMR-in-Namibia_FINAL.pdf. Accessed 6 May 2922.
  • Nakwatumbah S, Kibuule D, Godman B, et al. Compliance to guidelines for the prescribing of antibiotics in acute infections at Namibia’s national referral hospital: a pilot study and the implications. Expert Rev Anti Infect Ther. 2017;15(7):713–721.
  • Niaz Q, Godman B, Campbell S, et al. Compliance to prescribing guidelines among public health care facilities in Namibia; findings and implications. Int J Clin Pharm. 2020;42(4):1227–1236.
  • Niaz Q, Godman B, Massele A, et al. Validity of world health organisation prescribing indicators in Namibia’s primary healthcare: findings and implications. Int J Qual Heal Care. 2019;31(5):338–345.
  • Kibuule D, Nambahu L, Sefah IA, et al. Activities in Namibia to limit the prevalence and mortality from COVID-19 including community pharmacy activities and the implications. Sch Acad J Pharm. 2021;10(5):82–92.
  • Muwanguzi TE, Yadesa TM, Agaba AG. Antibacterial prescription and the associated factors among outpatients diagnosed with respiratory tract infections in Mbarara municipality, Uganda. BMC Pulm Med. [Internet]. 2021;21 (1):374. [cited 2022 May 5]. Available from. https://bmcpulmmed.biomedcentral.com/articles/10.1186/s12890-021-01739-5
  • Sefah IA, Essah DO, Kurdi A, et al. Assessment of adherence to pneumonia guidelines and its determinants in an ambulatory care clinic in Ghana: findings and implications for the future. JAC Antimicrob Resist. 2021;3 (2):dlab080.
  • Olaru ID, Meierkord A, Godman B, et al. Assessment of antimicrobial use and prescribing practices among pediatric inpatients in Zimbabwe. J Chemother. 2020;32(8):456–459.
  • Matsitse TB, Helberg E, Meyer JC, et al. Compliance with the primary health care treatment guidelines and the essential medicines list in the management of sexually transmitted infections in correctional centres in South Africa: findings and implications. Expert Rev anti-infective Ther. 2017;15(10):963–972.
  • Nambasa V, Ndagije HB, Serwanga A, et al. Prescription of Levofloxacin and Moxifloxacin in select hospitals in Uganda: a Pilot Study to Assess Guideline Concordance. Antibiotics Internet]. 2020;9:439. [cited 2022 May 5]. Available from: https://www.mdpi.com/2079-6382/9/8/439
  • Namibia medicine regulatory council M of H and SS. Namibia Medicine Register [Internet]. 2019. [cited 2022 May 5]. Available from: https://nmrc.gov.na/medicine-register.
  • Ministry of Health and Social Services. The Namibia ministry of health and social services (MoHSS). National Drug Policy for Namibia; 1998.
  • Ministry of Health and Social Services. Medicine and Related Substances Control Act, 2003 [Internet]. 4088 Namibia; 2013 p. 1–168. [cited 2022 May 5]. Available from: http://extwprlegs1.fao.org/docs/pdf/nam175073.pdf.
  • Ministry of Health and Social Services. National health policy framework 2010 - 2020. Windhoek Namibia: Ministry of Health and Social Services; 2010.
  • Government of the Republic of Namibia. Namibia medicine policy. Windhoek-Namibia: Ministry of Health and Social Services. 2009;1–302
  • Government of the Republic of Namibia. Animal Health Act [Internet]. 2011 p. 1–36. [cited 2022 May 5]. Available from: https://www.lac.org.na/laws/2011/4694.pdf.
  • World Health Organisation (WHO). Anatomical Therapeutic Chemical (ATC) Classification [Internet]. 2022 [cited 2022 May 2]. Available from 2022 May 2: https://www.who.int/tools/atc-ddd-toolkit/atc-classification
  • Mohulatsi D. Antibiotic use and resistance patterns in the Namibian private health sector [Internet]. 2016. [cited 2022 May 5]. Available from: https://dspace.nwu.ac.za/handle/10394/19755
  • Robertson J, Iwamoto K, Hoxha I, et al. Antimicrobial medicines consumption in Eastern Europe and Central Asia – an Updated Cross-National Study and Assessment of QuantitativeMetrics for Policy Action. Front Pharmacol. 2019;9.
  • Bojanić L, Marković-Peković V, Škrbić R, et al. Recent initiatives in the republic of srpska to enhance appropriate use of antibiotics in ambulatory care; their influence and implications. Front Pharmacol.
  • Fürst J, Čižman M, Mrak J, et al. The influence of a sustained multifaceted approach to improve antibiotic prescribing in Slovenia during the past decade: findings and implications. Expert Rev Anti Infect Ther. 2015;13 (2):279–289.
  • Robertson J, Vlahović-Palčevski V, Iwamoto K, et al. Corrigendum: variations in the consumption of antimicrobial medicines in the European Region, 2014–2018: findings and implications from ESAC-net and WHO Europe. Front Pharmacol. 2021;12.
  • Campbell SM, Meyer JC, Godman B. Why compliance to national prescribing guidelines is important especially across sub-Saharan Africa and suggestions for the future. J Biomed Pharm Sci. 2021;4.
  • Khan S, Engelbrecht F, Moyo S, et al. The antimicrobial susceptibility and gene based resistance of Streptococcus agalactiae (Group B Streptococcus), in pregnant women in Windhoek (Khomas region), Namibia. Med Technol SA. Internet]. 2017;30:9–14. [cited 2022 May 5]. Available from. http://www.mtsaj.co.za/index.php/mtsaj/article/view/136
  • Haimbodi EL, Mukesi M, Moyo SR. Prevalence and molecular characterization of group B streptococcus in pregnant women from hospitals in Ohangwena and Oshikoto regions of Namibia. BMC Microbiol. 2021;21(1):1–9.
  • Haimbodi EL, Mukesi M, Mtambo O, et al. Frequency of bacterial organisms isolated from cerebrospinal fluid (CSF) of children under five years in Windhoek from 2010 to 2014. Open J Med Microbiol. 2016;6(3):125–132.
  • Festus T, Mukesi M, Moyo S. The distribution of methicillin resistant of pathology in Windhoek, Namibia. Indian J Med Res Pharm Sci. 2016;3:1–8.
  • Vries AA. The effect of group a streptococcus on maternal and neonatal morbidity in Windhoek. 2019. Available at URL: https://ir.nust.na/jspui/bitstream/10628/721/1/Azaria%20Vries%20Thesis.pdf (cited 5 Many 2022)
  • Mengistu A, Gaeseb J, Uaaka G, et al. Antimicrobial sensitivity patterns of cerebrospinal fluid (CSF) isolates in Namibia: implications for empirical antibiotic treatment of meningitis. J Pharm Policy Pract. 2013;6(1)
  • Walter S, Böck R. Antibiotic resistance trends of Nasal Staphylococcal Isolates from Namibian school children. J Biosci Med. 2020.
  • Iileka AEK, Mukesi M, Engelbrecht F, et al. Antimicrobial susceptibility patterns ofstaphylococcus aureus strains isolated at the Namibia institute of Pathology from 2012 to 2014. Open J Med Microbiol. 2016;6(3):116.
  • Shilangale RP, Di Giannatale E, Chimwamurombe PM, et al. Prevalence and antimicrobial resistance pattern of Salmonella in animal feed produced in Namibia. Vet Ital. [Internet]. 2012;48:125–132. [cited 2022 May 13]. Available from. 2: http://www.ncbi.nlm.nih.gov/pubmed/22718330
  • Shilangale R, Kaaya G, Chimwamurombe P. Antimicrobial resistance patterns of salmonella strains isolated from beef in Namibia. Br Microbiol Res J. 2016;12(1):1–6.
  • Williams JD. Antibiotic use and resistance in the U.K. Chemotherapy. 1977;25:418–442.
  • Jatileni NJ, Maposa I, Mavenyengwa RT. A Retrospective Study of the Variability in Etiological Agents of Urinary Tract Infections among Patients in Windhoek-Namibia. Open J Med Microbiol. 2015;5(4):184–192.
  • Haindongo EH, Funtua B, Singu B, et al. Antimicrobial resistance among bacteria isolated from urinary tract infections in females in Namibia, 2016–2017. Antimicrob Resist Infect Control. 2022;11(1):1–8. [Internet]. Available from
  • Mengistu A, Forster N, Gaeseb J, et al. A review of empirical treatment of urinary tract infections based on national antimicrobial sensitivity data. Enliven Pharmacovigil Drug Saf. 2014;1(3):1–7.
  • Nangolo L. The distribution of Escherichia coli in pregnant women and antimicrobial susceptibility patterns of the isolates in selected rural areas in Namibia. 2018; [cited 2022 May 5]. Available from: https://ir.nust.na/handle/10628/699.
  • Smith AM, Keddy KH, De Wee L. Characterization of cholera outbreak isolates from Namibia, December 2006 to February 2007. Epidemiol Infect. 2008;136(9):1207–1209.
  • Tobias S, Shonhiwa S, Norbert F, Oke O, Ndjavera C, Chikukwa S, et al. P1-S1.10 Microbiological surveillance for sexually transmitted infections in Windhoek and Oshakati, Namibia (2007). Sexually Transmitted Infections. 2011;87(Suppl 1):A103-A.
  • Kamati M, Godman B, Kibuule D. Prevalence of self-medication for acute respiratory infections in young children in Namibia: findings and implications. J Res Pharm Pract. 2019;8 (4):220.
  • Pereko DD, Lubbe MS, Essack SY. Antibiotic use in Namibia: prescriber practices for common community infections. South Afr Fam Pract. 2015;57(4):231–235.
  • Kagoya HR, Mitonga H, Kibuule D, et al. National standard treatment guidelines: their impact on medicine use indicators in a resource-limited setting. J Pharm Heal Serv Res. 2021;12(1):61–68.
  • Naita B, Nghishekwa T. Trends in antibiotic consumption in the Namibian public health sector 2010-2016 [Internet]. 2018. [cited 2022 May 6]. Available from: https://www.semanticscholar.org/paper/Trends-in-antibiotic-consumption-in-the-Namibian-Nghishekwa/97938ca50bf83950d84322c73ae83b0833053f90
  • Pereko DD, Lubbe MS, Essack SY. Surveillance of antibiotic use in the private sector in Namibia using sales and claims data. J Infect Dev Ctries. 2016;10(11):1243–1249.
  • Kunda M, Haoses-Gorases L. An investigation of antibiotic prescribing in patients with upper respiratory tract infections (Urtis) at Katutura health centre, Windhoek, Namibia. Single Cell Biol. 2015;4. DOI:10.4172/2168-9431.1000122.
  • Akapabio E, Sagwa E, Mazibuko G, et al. Assessment of compliance of outpatient prescribing with the Namibia standard treatment guidelines in public sector health facilities [Internet]. Windhoek; 2014. [cited 2022 May 5]. Available from: https://siapsprogram.org/publication/assessment-of-compliance-of-outpatient-prescribing-with-the-namibia-standard-treatment-guidelines-in-public-sector-health-facilities/
  • Kagoya HR, Mitonga HK, Kibuule D, et al. National standard treatment guidelines: their impact on medicine use indicators in a resource-limited setting. Journal of Pharmaceutical Health Services Research. 2021;12(1):61–68.
  • Schellack N, Strydom M, Pepper MS, et al. Social media and COVID-19—perceptions and public perceptions of Ivermectin, Colchicine and Hydroxychloroquine: lessons for future pandemics. Antibiotics. 2022;11(4):445.
  • Namibian News paper. Namibia: ivermectin is no treatment for Covid-19 [Internet]. 2021. [cited 2022 May 2]: Available from. https://allafrica.com/stories/202104210894.html
  • Republic of Namibia Ministry of Health and Social Services. Namibia essential medicines list (nemlist). [Internet]. Windhoek; 2015. [cited 2022 May 4]. Available from. http://www.healthnet.org.na/Documents.html
  • Kibuule D, Mubita M, Naikaku E, et al. An analysis of policies for cotrimoxazole, amoxicillin and azithromycin use in Namibia’s public sector: findings and therapeutic implications. Int J Clin Pract. 2017;71 .
  • Republic of Namibia Ministry of Health and Social Services. Namibia standard treatment guidelines. [Internet]. Windhoek; 2012. [cited 2022 May 4]. Available from;http://www.healthnet.org.na/documents.html
  • Brinkmann I, Kibuule D. Effectiveness of antibiotic stewardship programmes in primary health care settings in developing countries. Res Soc Adm Pharm. 2020;16(9):1309–1313.
  • Joshi MP, Chintu C, Mpundu M, et al. Multidisciplinary and multisectoral coalitions as catalysts for action against antimicrobial resistance: implementation experiences at national and regional levels. Glob Public Health. 2018;13(12):1781–1795.
  • Mabirizi D, Kibuule D, Adorka M, et al. Promoting the rational medicine use of ARVs, Anti-TB, and other medicines and preventing the development of antimicrobial resistance in Namibia : workshop and stakeholders forum. 2013.
  • Public Health Scotland. Adopt AWaRe, handle antibiotics with care [Internet]. 53/2502. 2019. [cited 2022 May 4]. Available from: https://www.hps.scot.nhs.uk/publications/hps-weekly-report/volume-53/issue-25/adopt-aware-handle-antibiotics-with-care/
  • Hofer U. The cost of antimicrobial resistance. Nat Rev Microbiol. 2019;17(1):3.
  • Majumder MAA, Singh K, Hilaire MG, et al. HMTAR by promoting. Antimicrobial Stewardship in Medical and Allied Health Professional Curricula Expert Rev anti-infective Ther. 2020;18:1245–1258.
  • Cassini A, Hogberg LD, Plachouras D, et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European economic area in 2015: a population-level modelling analysis. Lancet Infect Dis. 2019;19(1):55–66.
  • Hao H, Cheng G, Iqbal Z, et al. Benefits and risks of antimicrobial use in food-producing animals. Front Microbiol. 2014;5.
  • Godman B, Haque M, McKimm J, et al. Ongoing strategies to improve the management of upper respiratory tract infections and reduce inappropriate antibiotic use particularly among lower and middle-income countries: findings and implications for the future. Curr Med Res Opin. 2020;36(2):301–327.
  • Alshaikh FS, Godman B, Sindi ON, Seaton RA, Kurdi A. Prevalence of bacterial coinfection and patterns of antibiotics prescribing in patients with COVID-19: A systematic review and meta-analysis. PLoS One. 2022;17(8):e0272375.
  • Sefah IA, Ogunleye OO, Essah DO, et al. Rapid assessment of the potential paucity and price increases for suggested medicines and protection equipment for COVID-19 across developing countries with a particular focus on Africa and the implications. Front Pharmacol. 2021;11.
  • Apley MD . Feedlot pharmaceutical documentation: protocols, prescriptions, and veterinary feed directives. Veterinary Clinics: Food Animal Practice. 2015;31(2):305–315.
  • Namibia medicine regulatory council M of H and SS. Guidance on the use of ivermectin in the management of Covid-19 in Namibia [Internet]. 2021. [cited 2022 May 6]. Available from: http://www.man.com.na/files/news/1611655279ivermectin—public-release.pdf
  • Namibian new paper. Namibians gobble up ivermectin as Covid cases soar. 2021 June 21 [Internet]. 2021;3. Available from: https://www.namibian.com.na/212489/archive-read/Namibians-gobble-up-ivermectin-as-Covid-cases-soar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.